Drug Patent Expirations in March 2013

Drug Patent Expirations for March 2013

TradenameApplicantGeneric NamePatent NumberPatent Expiration
THALOMIDCelgenethalidomide8,143,283Mar 1, 2013
THALOMIDCelgenethalidomide7,723,361Mar 1, 2013
THALOMIDCelgenethalidomide6,235,756Mar 1, 2013
ZOMETANovartiszoledronic acid4,939,130*PEDMar 2, 2013
LUNESTASunovion Pharms Inceszopiclone6,864,257*PEDMar 2, 2013
RECLASTNovartiszoledronic acid4,939,130*PEDMar 2, 2013
NATROBAParapro Llcspinosad5,496,931Mar 5, 2013
FLO-PREDTaroprednisolone acetate6,102,254Mar 11, 2013
ABRAXANEAbraxis Biosciencepaclitaxel5,498,421Mar 12, 2013
COMBIVENT RESPIMATBoehringer Ingelheimalbuterol sulfate; ipratropium bromide5,497,944Mar 12, 2013
RYBIX ODTShionogi Inctramadol hydrochloride5,464,632Mar 22, 2013
XOPENEXSunovionlevalbuterol hydrochloride5,362,755Mar 25, 2013
XOPENEX HFASunovionlevalbuterol tartrate5,362,755Mar 25, 2013
SILENORSomaxondoxepin hydrochloride5,502,047Mar 26, 2013
LOVAZASmithkline Beechamomega-3-acid ethyl esters5,502,077Mar 26, 2013
*Drugs may be covered by multiple patents or regulatory protections. See the DrugPatentWatch database for complete details.

Subscribers have access to valuable datasets, including:

  • Clinical trial information
  • International patent families
  • International patent priority and PCT information
  • Patent maintenance
  • Full-text patent downloads
  • Sales data (top 200 drugs)
  • Paragraph IV challenges
  • Tentative approvals
  • Dynamic search capabilities with data export
  • More…
See the Database Preview and Plan Comparison.
Contact Us with any questions.

Comments are closed.

Do NOT follow this link or you will be banned from the site!
%d bloggers like this: